🇺🇸 FDA
Patent

US 12257278

Methods of treating cancer with TNF expressing myxoma virus

granted A61KA61K35/14A61K35/28

Quick answer

US patent 12257278 (Methods of treating cancer with TNF expressing myxoma virus) held by ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY expires Mon Mar 20 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY
Grant date
Tue Mar 25 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 20 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61K, A61K35/14, A61K35/28, A61K35/768, A61K38/191